Sara H. Al Breiki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sara H. Al Breiki has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Guzman-Holst
GSK, London, UK
1 shared publication - Aljawharah K. Alsaleh
College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
1 shared publication - Almakrami Mohammed
Albert Szent-Gyorgyi Medical School, University of Szeged, Szeged, Hungary
1 shared publication - Juman O. Alammar
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
1 shared publication - Mansour Khalaf
GSK, Jeddah, Saudi Arabia
1 shared publication - Maryam Mohammed Alfaraj
Collage of Medicine, Imam Abdulrhman bin Faisal University, Dammam, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 1 November 2025
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 22 (6) , em692
Retronychia: A comprehensive review of etiologies, clinical manifestations, diagnostics, and management
Retronychia, a rare nail disorder that includes the ingrowth of the proximal nail plate into the proximal nail fold. This condition often leads to the misplacement of nail plates and significant discomfort for patients. It mainly affects younger females, and is more frequently observed in toenails, especially the big toe. Patients typically present with symptoms such as redness, pain, inflammation, and discharge from the affected area. This condition is often misdiagnosed, which can result in chronic pain and further complications. This narrative review aims to consolidate and analyze the existing literature on retronychia, encompassing its pathophysiology, risk factors, clinical features, classification, diagnostic methods, and treatment options. By providing a comprehensive overview, this work seeks to serve as a crucial resource for healthcare professionals and researchers. Ultimately, enhancing awareness and understanding of retronychia can lead to improved diagnosis and management strategies for affected individuals.
- 1 November 2025
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 22 (6) , em692
Open AccessRetronychia: A comprehensive review of etiologies, clinical manifestations, diagnostics, and management
Retronychia, a rare nail disorder that includes the ingrowth of the proximal nail plate into the proximal nail fold. This condition often leads to the misplacement of nail plates and significant discomfort for patients. It mainly affects younger females, and is more frequently observed in toenails, especially the big toe. Patients typically present with symptoms such as redness, pain, inflammation, and discharge from the affected area. This condition is often misdiagnosed, which can result in chronic pain and further complications. This narrative review aims to consolidate and analyze the existing literature on retronychia, encompassing its pathophysiology, risk factors, clinical features, classification, diagnostic methods, and treatment options. By providing a comprehensive overview, this work seeks to serve as a crucial resource for healthcare professionals and researchers. Ultimately, enhancing awareness and understanding of retronychia can lead to improved diagnosis and management strategies for affected individuals.
- Open Access
- 3 December 2022
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 12 (1) , 81-93
Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature
Introduction The reactivation of varicella zoster virus (VZV) in previously infected individuals can cause herpes zoster (HZ), which is characterized by a localized, painful dermatomal rash. While there is a global trend of increasing HZ cases, there is a lack of research examining the epidemiology of HZ within the Gulf Cooperation Council (GCC) countries. Therefore, we aimed to critically appraise evidence on VZV and HZ epidemiology in the GCC countries and identify gaps in the current literature. Methods A literature review was conducted via a comprehensive appraisal of the literature. PubMed and local-language journals were searched to identify articles related to HZ and VZV published up until 31 January 2022, with a sole focus on the GCC countries. Included studies reported on surveillance data, seroepidemiology, and patient outcomes for HZ and VZV, and comprised primary data reports, case series, case reports, narrative and systematic literature reviews, studies reporting HZ incidence or prevalence, and Ministry of Health reports. Results Thirteen studies were found that reported on VZV seroprevalence in Saudi Arabia, the United Arab Emirates (UAE), and Qatar, ranging from 15.0% to 92.2%, while no data were identified for Bahrain, Kuwait, or Oman. There was very limited country-wide information on the incidence of HZ in GCC countries, and three identified studies reported HZ prevalence as seen in a single clinic, ranging from 0.62% to 2.3%. A single study from Saudi Arabia and government surveillance data reported on the impact of VZV vaccination on VZV infection, though there was no evidence on the impact of VZV vaccination on HZ. Conclusion There is a clear gap in the literature regarding the incidence of HZ infection, and the impacts of HZ and VZV vaccinations in the GCC countries. Further research into the epidemiology of HZ is necessary to inform the implementation of vaccination programs in the GCC countries. Graphical Abstract
- 3 December 2022
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 12 (1) , 81-93
Open AccessEpidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature
Introduction The reactivation of varicella zoster virus (VZV) in previously infected individuals can cause herpes zoster (HZ), which is characterized by a localized, painful dermatomal rash. While there is a global trend of increasing HZ cases, there is a lack of research examining the epidemiology of HZ within the Gulf Cooperation Council (GCC) countries. Therefore, we aimed to critically appraise evidence on VZV and HZ epidemiology in the GCC countries and identify gaps in the current literature. Methods A literature review was conducted via a comprehensive appraisal of the literature. PubMed and local-language journals were searched to identify articles related to HZ and VZV published up until 31 January 2022, with a sole focus on the GCC countries. Included studies reported on surveillance data, seroepidemiology, and patient outcomes for HZ and VZV, and comprised primary data reports, case series, case reports, narrative and systematic literature reviews, studies reporting HZ incidence or prevalence, and Ministry of Health reports. Results Thirteen studies were found that reported on VZV seroprevalence in Saudi Arabia, the United Arab Emirates (UAE), and Qatar, ranging from 15.0% to 92.2%, while no data were identified for Bahrain, Kuwait, or Oman. There was very limited country-wide information on the incidence of HZ in GCC countries, and three identified studies reported HZ prevalence as seen in a single clinic, ranging from 0.62% to 2.3%. A single study from Saudi Arabia and government surveillance data reported on the impact of VZV vaccination on VZV infection, though there was no evidence on the impact of VZV vaccination on HZ. Conclusion There is a clear gap in the literature regarding the incidence of HZ infection, and the impacts of HZ and VZV vaccinations in the GCC countries. Further research into the epidemiology of HZ is necessary to inform the implementation of vaccination programs in the GCC countries. Graphical Abstract